Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells.
Simbulan-Rosenthal CM, Haribabu Y, Vakili S, Kuo LW, Clark H, Dougherty R, Alobaidi R, Carney B, Sykora P, Rosenthal DS.
Simbulan-Rosenthal CM, et al. Among authors: rosenthal ds.
Int J Mol Sci. 2022 Feb 20;23(4):2333. doi: 10.3390/ijms23042333.
Int J Mol Sci. 2022.
PMID: 35216449
Free PMC article.